TargetDx Laboratory

Valparaiso, Indiana, United States

Diagnostics Screening & Early Detection Biomarker Monitoring AI / ML

TargetDx Laboratory, located in Michigan City, Indiana, is a medical device company dedicated to creating a groundbreaking blood test for the early detection of Non-Small Cell Lung Cancer (NSCLC). Our test, developed using a combination of protein biomarkers and proprietary machine learning algorithms delivers a highly sensitive and specific risk assessment for early-stage lung cancer. Our choice to focus on protein markers is rooted in their ability to reflect the physiological state of tissue, giving us a real-time picture of the interplay between genetics and the environment. This focus has not only led to the discovery of novel markers linked to lung cancer but has also allowed us to validate existing markers for diagnostic use, culminating in multiple patents and research publications.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out TargetDx Laboratory on @MedStartr Today #LungCancer #EarlyCancerDetection #Diagnostics #ScreeningEarlyDetection #BiomarkerMonitoring #AIML #MedMo #MedStartrVentures

https://www.medstartr.ai/s/OjoKWrJcTmw

Get Involved in TargetDx Laboratory

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2018
Website: www.targetdxlab.com/

Disease Areas

Lung Cancer Early Cancer Detection

Technologies

BiomarkersMachine LearningAlgorithmsPredictive Analytics

🌐Website

What do you think of TargetDx Laboratory?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.